Management of patients with intermediate stage hepatocellular carcinoma

Hepatocellular carcinoma (HCC) causes a significant health burden globally and its impact is expected to increase in the coming years. Intermediate stage HCC, as defined by the Barcelona Clinic Liver Cancer (BCLC) system stage B, represents up to 30% of patients at diagnosis and encompasses a broad...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Med Oncol
Hlavní autoři: Prince, David, Liu, Ken, Xu, Weiqi, Chen, Minjiang, Sun, Jin-Yu, Lu, Xiao-Jie, Ji, Jiansong
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2020
Témata:
Early Diagnosis and Therapeutic Advances for Liver Cancer: From Bench to Bedside
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649909/
https://ncbi.nlm.nih.gov/pubmed/33224278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920970840
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky